The largest database of trusted experimental protocols

6 protocols using dynabeads

1

Cytokine Production in T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were stimulated with CD3/CD28 Dynabeads (1:1 ratio) or Dynabeads plus 25 ng/ml TGFβ (Miltenyi Biotec, Bergisch Gladbach, Germany). 24 hours later eBioscience Brefeldin A Solution (1000X) (ThermoFisher Scientific) was added and incubated for 4 hours. Cells were stained with extracellular antibodies 7-AAD, CD8-APC/Cy7, CD4-FITC (BioLegend) and intracellular antibodies IFN-γ-PE, IL-2-APC (BD Biosciences) and TNF-α-PacificBlue (BioLegend) using FIX & PERM Cell Fixation & Cell Permeabilization Kit (ThermoFisher Scientific) according to the manufacturer’s information.
+ Open protocol
+ Expand
2

Isolation of Cerebral Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The physicians used real-time X-ray technology to visualize the patient’s vascular system and locate IA inside the blood vessel. A solitaire stent retriever (Covidien, Irvine, CA, United States) was used for biopsy specimens’ retrieval from an occluded IA. Cerebral aneurysm and malformed arteries were isolated from cerebral arties using a cutting plane and separating the surfaces on either side of the plane by using a minimally invasive technique. Endothelial cells were derived from human cerebral aneurysm and malformed arteries, and separated with immunomagnetic cell sorting. Briefly, Anti-CD 146-coated Dynabeads (Invitrogen, CA, United States) were prepared according to manufacturer’s instruction and stored at 4°C. Fifty-mg aneurysms were ground with glass pestle and mortar with one-millilter PBS buffer, 0.1% bovine serum albumin, 0.1% sodium azide, and 0.1% a standard broad-spectrum inhibitor cocktail at 4°C. Ten-microliter FcR-blocking agent (Miltenyi, Bergisch Gladbach, Germany) and 25-microliter antibody-coated Dynabeads were added and mixed thoroughly. The samples were mixed in a mixer for 1 h at 4°C and washed four times with PBS inside the Big Easy Magnet (EasySep, United States) at 4°C. Between each washing procedure, the endothelial cells were flushed out with MACS buffer (PBS with 0.5% BSA and 2 mM EDTA, pH 7.0) 10 times in a 100-μL pipette.
+ Open protocol
+ Expand
3

T-Cell Activation and Expansion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+/CD45RA/CD62L+ T cells were isolated from healthy donor whole blood obtained from the UCLA Blood and Platelet Center, stimulated with CD3/CD28 T-cell activation Dynabeads (Life Technologies) at a 1:1 bead:cell ratio, and lentivirally transduced 72 h later at a multiplicity of infection of 1.5. All T cells were expanded in complete T-cell medium supplemented with penicillin-streptomycin (100 U/mL, Life Technologies) and fed interleukin 2 (IL2, 50 U/mL, Life Technologies) and IL15 (1 ng/mL, Miltenyi) every 48 h. Dynabeads were removed 9 or 10 days post-isolation. CAR+ cells were enriched by magnetic bead-based sorting (Miltenyi) and expanded by stimulation with irradiated TM-LCLs at a T cell:TM-LCL ratio of 1:7. Mock-transduced T cells were stimulated using the rapid expansion protocol as previously described (20 (link)). Each in vitro experiment was repeated with T cells from different donors (T cells were never pooled). See Supplementary Materials and Methods for additional details.
+ Open protocol
+ Expand
4

Isolation and Activation of Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were isolated from healthy donor’s PBMCs (Zen-Bio, Durham, NC, USA) using the human Pan T cell Isolation Kit (Miltenyi Biotec, North Rhine-Westphalia, Germany) and stimulated with CD3/CD28 T cell activator Dyna beads (Gibco) at 1:1 cell- bead ratio in X-VIVO 15 (Lonza, Basel, Switzerland). The cells were supplemented with 2% human serum (Sigma-Aldrich) and 50IU/ml IL-2 (Miltenyi Biotec). 48h after initiating T cell activation, Dyna beads were removed and the medium was exchanged for TEXMACS (Miltenyi Biotec) including 50IU/ml IL-2 for T cell expansion. The activated T cells were used for the cytotoxicity assay of CAR-T and IgG-based bispecific T cell engager (IbTE) antibodies.
+ Open protocol
+ Expand
5

Naïve B Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sorting was conducted using BD FACS ARIA II (BD Biosciences, San Diego, CA, USA) to acquire naïve B cells (defined as CD27-IgD+CD19+ cells) from HC subjects’ PBMCs. Naïve CD4+ T cells (1 ×105 cell cells each/well) after stimulating with the RPMI complete medium, dynabeads® human T-activator CD3/CD28 or HBV-ACLF patients’ serum were cultured with 2 ×105 naïve B cells (defined as CD27-IgD+CD19+ cells) in the presence of a surperantigen (Cytostim, human, Miltenyi Biotec) in RPMI-1640 with 10% heat-inactivated fatal bovine serum. The proliferation of B cells was evaluated using a CFSE dilution assay.
+ Open protocol
+ Expand
6

Immunofluorescent Staining of Circulating Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BD Pharm Lyse lysing solution and Lyse/Fix Buffer were purchased from BD Biosciences (San Jose, CA, USA). The FcR blocking reagent and CD45 Microbeads (Dynabeads, DYNAL) were purchased from Miltenyi Biotec (Bergisch‐Gladbach, Germany) and Invitrogen (Carlsbad, CA, USA), respectively. The FITC‐conjugated anti‐cytokeratin (CK) mAb CK3‐6H5, phycoerythrin (PE)‐conjugated anti‐CD326 (EpCAM) mAb 9C4, and Alexa Fluor 700‐conjugated anti‐CD45 mAb F10‐89‐4 were purchased from Miltenyi Biotec, BioLegend (San Diego, CA, USA) and AbD Serotec (Oxford, UK), respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!